Mindray Medical International Limited announced during the past week that two medical products have received 510(k) clearance for US use from the FDA. One product, the AS3000 next generation anesthesia delivery system, was developed by Mindray’s recent acquisition, Datascope Patient Monitoring. The other recently approved product adds a product in the lower price range of Mindray's ultrasound line: the DC-3 color ultrasound imaging system. More details...

Stock Symbol: (NYSE: MR)